Skip to main content

M R22 (Repaglinide 1 mg)

Pill with imprint M R22 is Blue, Round and has been identified as Repaglinide 1 mg. It is supplied by Mylan Pharmaceuticals Inc.

Repaglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 1 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M R22

Repaglinide 1 mg M R22

Repaglinide

Imprint
M R22
Strength
1 mg
Color
Blue
Shape
Round
Availability
Prescription only
Drug Class
Meglitinides
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
butylated hydroxyanisole, silicon dioxide, corn starch, croscarmellose sodium, calcium phosphate dibasic anhydrous, magnesium stearate, meglumine, microcrystalline cellulose, polacrilin potassium, sodium lauryl sulfate, FD&C Blue No. 1

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-3122 (Discontinued) Mylan Pharmaceuticals Inc.
51079-0539 (Discontinued) UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related images for "M R22"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.